Pharmaceutiques (France's number one pharma magazine) offers you a great opportunity to capitalize on its industry experience by subscribing to its latest publication - BioPharmaceutiques, now available in English and French.

With weekly delivery of high-quality content to your e-mail inbox and 24/7 web-based access to the latest biotech information, comprehensive summary tables and all back issues, BioPharmaceutiques interprets the sector's news from both a pharma perspective and a resolutely European angle. In short, BioPharmaceutiques provides sector stakeholders with a rapidly assimilated synopsis of who is doing what and with whom.

High-quality content:
European biotech news at a glance

BioPharmaceutiques focuses in on the latest IPOs, M&A activity, investment rounds, clinical trial launches, industry appointments and news on European directives and regulations. Your time is precious, so the BioPharmaceutiques e-newsletter gives you immediate access to a list of headlines with hyperlinks to the full article.

Drilling down:
our interactive summary tables

Along with weekly updates from the latest editions of the magazine, the dedicated BioPharmaceutiques website gives subscribers 24/7 access to regularly updated summary tables, with interactive molecule-, company- and disease-specific overviews of the latest corporate alliances, clinical trial launches, investments and IPOs.

Cost-effective access:
a single corporate subscription for your whole company

We offer a subscription format which is clear and straightforward - offer all your employees access to BioPharmaceutiques, with no restrictions on numbers and in full compliance with intellectual property rights.

Just send us a list of your company's subscriber names and e-mail addresses or a single corporate distribution address. As soon as your subscription has been processed, you will automatically start to receive the BioPharmaceutiques newsletter. Once you have received your full subscriber details, you will be able to access the exclusive content and resources on the BioPharmaceutiques website.

SUBSCRIPTION RATES
Pharmaceutical companies: €3,000 + VAT per annum
Biotech companies with a turnover > €20 million: €3,000 + VAT per annum
Biotech companies with a turnover < €20 million and other subscribers: €1,000 + VAT per annum.
Other category: €1,000

To subscribe, fill out the form located here.